Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: Results from the SENTRY Antimicrobial Surveillance Program (1997)

Clinical Microbiology and Infection

Volumn 5, Issue 8, 1999, Pages 478-487

  Sader, Helio S ^a,l   Jones, Ronald N ^b   Winokur, Patricia L ^b   Pfaller, Michael A ^b   Doern, Gary V ^b   Barrett, Timothy ^b   Sampaio, J ^c   Zoccoli, C ^d   Casellas, J M ^e   Smayevsky, J ^f   Prado, V ^g   Palavecino, E ^h   Bagnulo, H ⁱ   Robledo, J A ^j   Osornio, J S ^k  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

^c Lamina Laboratory   (Brazil)

^d Santa Luzia Medical Laboratory   (Brazil)

^e Ctro de Estudios en Antimicrobianos   (Argentina)

^f CEMIC   (Argentina)

^g UNIVERSITY OF CHILE   (Chile)

^h PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

ⁱ Hospital Maciel   (Uruguay)

^j Unidad de Biología Celular y Molecular   (Colombia)

^k INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^l NONE

more..

Author keywords

Antimicrobial resistance surveillance; SENTRY Antimicrobial Surveillance Program; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DOXYCYCLINE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; MONOBACTAM; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; STREPTOMYCIN; TETRACYCLINE; TICARCILLIN; TROVAFLOXACIN; UNINDEXED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DEVICE; DILUTION; ENTEROBACTER; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOUTH AND CENTRAL AMERICA; URINARY TRACT INFECTION;

EID: 0032883769     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00177.x     Document Type: Article

References (24)

1. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997; 11: 609-22.
2. Platt R, Polk BR, Murdock B, et al. Mortality associated with nosocomial urinary tract infection. N Engl J Med 1982; 307: 637-42.
3. Koracevich DS, Faubion WC, Bender JM, et al. Association of parenteral nutrition catheter sepsis with urinary tract infections. J Parent Enter Nutr 1986; 10: 639-41.
4. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996; 100(suppl 6A): 3S-12S.
5. Jones RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on antibiotic resistance. Diagn Microbiol Infect Dis 1996; 25: 153-61.
6. Sader HS, Mimica I, Rossi F, et al. Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from 18 Brazilian hospitals by using the Etest. Diagn Microbiol Infect Dis 1997; 28: 87-92.
7. Gales AC, Sader HS, Mimica I, et al. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobial agents against 2085 clinical isolates tested in 13 Brazilian centers. Braz J Infect Dis 1997; 1: 294-305.
8. Pfaller MA, Jones RN, Doern GV, Kugler K, the Sentry Participants Group. Bacterial pathogens isolated from patients with blood stream infection: frequencies of occurrence and antimicrobial susceptibility patterns from SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-70.
9. Sader HS, Jones RN, Gales AC, et al. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY antimicrobial surveillance program (1997). Diagn Microbiol Infect Dis 1998; 32: 289-301.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved Standard M7-A4. Wayne, PA: NCCLS, 1997.
11. Pfaller MA, Wendt C, Hollis RJ, et al. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis 1996; 25: 1-8.
12. Pfaller MA, Hollis RJ, Sader HS. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In Isenberg HD, ed. Clinical microbiology procedures handbook, Vol. 2. Washington, DC: American Society for Clinical Microbiology, 1992: 10.5c. 1-12.
13. Sader HS, Pfaller MA, Jones RN. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and inter-laboratory dissemination of extended spectrum β-lactamase producing Enterobacteriaceae. Diagn Microbiol Infect Dis 1994; 20: 203-8.
14. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob Agents Chemother 1994; 38: 761-6.
15. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990; 34: 858-62.
16. Martinez-Martinez L, Hernandez-Alles S, Alberti S, Tomas JM, Benedi VJ. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 342-8.
17. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
18. Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in southern Israel, 1991-1995. Eur J Clin Microbiol Infect Dis 1997; 16: 834-8.
19. Sader HS, Mendes CF, Pignatari AC, Pfaller AC. Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in Sao Paulo, Brazil. Clin Infect Dis. 1996; 23: 631-4.
20. Emory CL, Weymouth LA. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 2061-7.
21. Sirot DL, Goldstein FW, Soussy CJ, et al. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother 1992; 36: 1677-81.
22. Gales AC, Bolmstrom A, Jones RN, Reis AO, Sader HS. Prevalence, antimicrobial susceptibility and molecular typing of extended-spectrum β-lactamase producing Klebsiella pneumoniae from Brazil [abstract no. D-13]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington DC: American Society for Microbiology, 1997: 85.
23. Rossi A, Tokumoto M, Corso A, Soloaga R, Galas M, O'Brian T. Actividad de antimicrobianos betalactamicos, aminoglucosidos y fluoroquinolonas frente a bacilos gram negativos en Argentina (1994-1995) [abstract no. 226]. In: Program and abstracts of the XII Congreso Latinoamericano de Microbiologia, Caracas, Venezuela. 1996, 210.
24. Hayden MK, Schiappa DA, Matushek MG, Trenholme GM. In vivo development of ceftazidime resistance in a strain of Klebsiella pneumoniae due to an extended spectrum β-lactamase (ESBL) [abstract no. 754]. In: Program and abstracts of the 35th Annual Meeting. San Francisco, USA. Alexandria, VA: Infectious Disease Society of America 1997: 211.